This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Index levels move with price changes, weighting shifts, and market events. This overview highlights the main drivers behind index fluctuations.
20,883 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...
AST SpaceMobile posted a Q1 2026 revenue miss but reaffirmed full-year guidance and outlined a rapid satellite deploy...
Biotech investing hinges on milestones and discipline. This article breaks down inmune (INMB) 2025 earnings, what the...
NVIDIA shares pulled back amid an AI sector-wide retreat, but a growing data-center footprint and a record order book...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
Investors are watching whispers about Apple and Intel teaming up. This article breaks down what that could mean for s...
A UK-listed bitcoin treasury company uncovers a counterintuitive edge: buying back its own stock can yield about 24% ...
A mid-cap tech stock has quietly outperformed NVIDIA on a three-year price-return basis, triggering renewed interest ...
Power Solutions International plunged today amid a tech and energy-led market pullback. This analysis breaks down the...
IonQ posted triple-digit revenue growth for 2025, reaching a new high, while losses intensified. The stock has fallen...
When headlines talk about a stock suddenly bleeding, traders worry about customer losses and slowing growth. This art...